Le Lézard
Classified in: Ebola virus, Health, Covid-19 virus
Subject: MRR

Global In Vitro Diagnostic (IVD) Procedure Volumes Report 2023-2028: Total Number of IVD Tests by Region and Selected Countries/Average and Total Worldwide Cost of Various IVD Tests


DUBLIN, Jan. 4, 2024 /PRNewswire/ -- The "In Vitro Diagnostic (IVD) Procedure Volumes (Chemistry, Immunoassays, Hematology, Microbiology, Histology, Point of Care), 2023-2028" report has been added to ResearchAndMarkets.com's offering.

Research_and_Markets_Logo

In vitro diagnostic (IVD) test volumes are the gold standard for sizing the market opportunity for new entrants with diagnostic products, and they can be useful for existing product marketers.

The market analysis in the report saves time with calculations and estimates of both the existing number of procedures for scores of diagnostic tests and the future potential. In the process, pricing analysis is also performed. This report is an essential resource for the IVD business planner.

Scope

Data statistics appearing in this report correlate to IVD procedures based on commercially sold and distributed tests. Procedures that employ laboratory-developed tests (LDTs) and tests implemented for research purposes only are excluded from the analysis.

Global volumes of various IVD procedures are presented in millions and reflect the evaluation of a single analyte, marker, or other variable of interest. It should be noted that some IVD tests involve more than one procedure as they provide for the analysis of multiple analytes.

Global sales of IVD products are expressed in current United States dollars and reflect sales for the year 2023 and forecasts for the 2028 period. A table that measures the total amount of IVD product sales against the total volume of IVD procedures is presented for each major testing category.

The IVD procedures report presents projections covering the 2023 to 2028 period for:

Key Topics Covered:

Chapter One: Executive Summary

Chapter Two: Introduction

Chapter Three: IVD Testing Segments

Chapter Four: Global IVD Markets

Chapter Five: Point-of-Care (POC) Procedures

Chapter Six: Clinical Chemistry Procedures

Chapter Seven: Immunoassay Procedures

Chapter Eight: Molecular Testing Procedures

Chapter Nine: Laboratory-Based Hematology Procedures

Chapter Ten: Coagulation Testing Procedures

Chapter Eleven: Microbiology Procedures

Chapter Twelve: Blood Grouping/Typing Procedures

Chapter Thirteen: Histology/Cytology Procedures

Chapter Fourteen: Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/1hxwyb

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]   
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

 

SOURCE Research and Markets


These press releases may also interest you

21 mar 2019
The "Europe Welding Equipment Market-Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering. Welding is one of the critical processes employed in the manufacturing...

21 mar 2019
Inovio Pharmaceuticals, Inc. announced today that its Ebola vaccine, INO-4201, was safe, tolerable, and generated strong T cell and antibody responses. This Phase 1 data was published in The Journal of Infectious Diseases and further supports the...

20 mar 2019
Merck , known as MSD outside the United States and Canada, and NGM Biopharmaceuticals, Inc. (NGM) today announced that Merck has exercised its option to extend the research phase of the companies' broad, strategic collaboration...

20 mar 2019
The shareholders in Sandvik Aktiebolag are convened to the Annual General Meeting to be held on Monday, 29 April 2019 at 3:00 p.m. at the Göransson Arena, Sätragatan 21, Sandviken, Sweden. RIGHT TO PARTICIPATE AND NOTICE Shareholders who wish to...

20 mar 2019
The Oslo Business for Peace Award is given to inspiring business leaders who have put society first. 2019's winners are: Dr Agbor Ashumanyi Ako, medical director of GiftedMom, Alice Laugher, CEO of Committed to...

19 mar 2019
The evolving competitive market has made it essential for the telecommunication industry to rethink traditional ways of doing business in terms of the impact on business models, service portfolios and technical architectures. Digital business support...



News published on and distributed by: